跳至主要内容
临床试验/IRCT20100127003217N13
IRCT20100127003217N13招募中3 期

Evaluation of the therapeutic effects of saffron (Crocus sativus) on clinical and electrodiagnostic symptoms of patients with type 2 diabetes: a double-blind clinical trial

Tabriz University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Having type 2 diabetes
  • Symptoms of sensory neuropathy such as numbless, burning and pain, muscle weakness, atrophy and balance disorders
  • Age more than 18 years
  • Body mass index (BMI) 18.5–35 kg / m
  • Recent diagnosis (maximum 3 months) of type 2 diabetes
  • Willingness to participate in the study

排除标准

  • Having type 1 diabetes
  • Gestational diabetes or other specific types of diabetes
  • Insulin therapy over the past three months
  • Having serious gastrointestinal (GI) diseases including peptic ulcers and gastrointestinal bleeding
  • Having an autoimmune disease
  • Osteoarthritis (due to masking the symptoms of neuropathy)
  • Having a history of inherited neuropathy
  • Chronic uremia
  • Allergy to saffron
  • Use of drugs that affect on the symptoms of neuropathy such as antidepressants and anticonvulsants

研究者

相似试验